Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation

Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation

Abstract MYC upregulation is associated with multidrug refractory disease in patients with multiple myeloma (MM). We, isolated patient-derived MM cells with high MYC expression and discovered that NCOR2 was down-regulated in these cells. NCOR2 is a transcriptional coregulatory protein and its role i...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomoaki Mori, Rakesh Verma, Rie Nakamoto-Matsubara, Ka Tat Siu, Cristina Panaroni, Keertik S. Fulzele, Kenta Mukaihara, Chukwuamaka Onyewadume, Allison Maebius, Hiroki Kato, Lai Ping Wong, Ruslan I. Sadreyev, David T. Scadden, Noopur S. Raje
Format: article
Language:EN
Published: Nature Publishing Group 2021
Subjects:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Online Access:https://doaj.org/article/b338d530f2da4568b81bbdf194813434
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/b338d530f2da4568b81bbdf194813434

Similar Items